news

Our latest
Press Releases & Updates

Latest press releases

RetinAI receives Innosuisse certificate

RetinAI Medical has received the prestigious Innosuisse Certificate of quality, which is awarded to Swiss startup companies ready for growth & scale-up.

RetinAI Announces Collaboration with Novartis to Provide Artificial Intelligence Solutions in Ophthalmology

RetinAI Medical AG announced a multi-year collaboration with Novartis Pharma AG under which RetinAI’s IT solutions and artificial intelligence tools shall be employed to support multiple projects in ophthalmology and digital health.

RetinAI receives ISO 13485:2016 certification

RetinAI has just received the ISO 13485:2016 certification, an important recognition awarded by regulatory bodies and necessary for companies willing to develop and commercialise Medical Devices.

btov Partners leads CHF 2.3M investment into RetinAI to bring Artificial Intelligence to Health Data

RetinAI, a Bern based company building software tools to aggregate, manage, and analyse health data, has closed a CHF 2.3M pre-Series A financing round. btov Partners' Industrial Technologies Fund has led the round with participation of Swiss-based investor network Investiere and a consortium of selected private investors...

Latest updates

RetinAI in RTS- Swiss television

The last week of August we received the Swiss Television (SRF - Schweizer Radio und Fernsehen) at our offices in Bern.We talked for a few minutes about what we do and how artificial intelligence is going to change ophthalmology and healthcare in the near future!

Watch it here

Arvo 2019 - Vancouver [MAY’19]

RetinAI had a great conference at this year at ARVO 2019, with more than 15’000 attendees from all over the world!Congratulations to the team for these amazing 5 days of work and for the success on the official release of our two main products: OmniViewer and RetinAI Discovery.

Democratising Access to Health Care - INVESTIERE [APRIL’19]

"Automation does not replace jobs, it replaces tasks" - Learn how RetinAI applies machine learning to medical imaging, not to replace eye doctors, but to make their work less tedious. Via Investiere Venture Capital - Read more

RetinAI in FORBES FR [DECEMBER’18]

RetinAI is honoured to be in December's edition of Forbes France! Artificial Intelligence is changing the world of ophthalmology by democratising access to high-quality eye-care for everyone. Discover a bit more about the future of healthcare in 2019, starting with your eyes! [FR]

Contact us for more informations! We are happy to hear from you!